Increasing literatures show that PPARα or PPARγ can inhibit tumor progression by multiple pathways, which can be the potential therapeutic targets for cancer treatment, while some agonists suppress tumor progression in a PPARα/γ- independent manner (Figure 1, Figure 3). This evidence concerns the gene PPARG and cancer.